Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BLVRBP1, or BLVRB pseudogene 1, is a genomic locus in the human genome resembling the functional biliverdin reductase B (BLVRB) gene. Unlike its functional counterpart, BLVRBP1 is a pseudogene, which means it does not produce a functional protein product and is not involved in catalytic activity, signaling, or recognized disease pathways. While the functional enzyme BLVRB is implicated in heme metabolism, redox regulation, and certain disease models[1][5], no experimental or clinical evidence associates BLVRBP1 with any biological or therapeutic role. Relevant context: - If you are seeking information on the active enzyme, refer to biliverdin reductase B (BLVRB)[1][3][5]. That is a well-described, canonical enzyme involved in heme degradation, with possible roles in cancer and inflammatory processes. - The pseudogene BLVRBP1 should not be confused with the functional gene or its protein product[1][5]. If your intention was to collect pharmacological or biomedical information, you should consider biliverdin reductase B (BLVRB), not its pseudogene BLVRBP1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BLVRB pseudogene 1 (BLVRBP1).